TabletsClinical Overview
Cefuroxime (as Cefuroxime Axetil for oral use or Cefuroxime Sodium for parenteral use) is a second-generation cephalosporin antibiotic. It resists degradation by many bacterial beta-lactamases and possesses bactericidal action against a broad spectrum of Gram-positive and Gram-negative organisms, including beta-lactamase-producing H. influenzae, Moraxella catarrhalis, S. pneumoniae, and S. aureus. Indicated for acute bacterial sinusitis, tonsillitis, acute otitis media, acute exacerbations of chronic bronchitis, uncomplicated UTIs, early Lyme disease, and surgical prophylaxis.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Swallow the tablet whole with water immediately following a meal. Taking cefuroxime axetil with food significantly increases systemic bioavailability. Do not crush or chew tablets due to a persistent strong bitter taste.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Diarrhea, nausea, vomiting, abdominal pain, headache, and transient elevation of liver enzymes. Rare/Severe: Pseudomembranous colitis, anaphylactic shock, erythema multiforme, and Jarisch-Herxheimer reaction in Lyme disease.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Contraindicated in cephalosporin allergy. Caution in penicillin-allergic patients. Do not crush tablets. Adjust dose in patients with impaired renal function.
Schedule H (Prescription Required)
This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered medical practitioner or qualified pharmacist before initiating, modifying, or substituting any medication regimen.
Amoxycillin 1g + Potassium Clavulanate 200mg Injection
Amoxycillin and Potassium Clavulanate is a synergistic broad-spectrum antibacterial combination. Amoxycillin, an extended-spectrum aminopenicillin, inhibits bacterial cell wall peptidoglycan synthesis, while clavulanic acid, a beta-lactamase inhibitor, competitively binds and inactivates beta-lactamase enzymes produced by resistant bacteria, thereby safeguarding amoxycillin from enzymatic degradation. Indicated for acute otitis media, bacterial sinusitis, community-acquired pneumonia, skin and skin structure infections, recurrent urinary tract infections, and post-operative dental and surgical infections.
Amoxycillin 200mg + Potassium Clavulanate 28.5mg Oral Suspension per 5ml
Amoxycillin and Potassium Clavulanate is a synergistic broad-spectrum antibacterial combination. Amoxycillin, an extended-spectrum aminopenicillin, inhibits bacterial cell wall peptidoglycan synthesis, while clavulanic acid, a beta-lactamase inhibitor, competitively binds and inactivates beta-lactamase enzymes produced by resistant bacteria, thereby safeguarding amoxycillin from enzymatic degradation. Indicated for acute otitis media, bacterial sinusitis, community-acquired pneumonia, skin and skin structure infections, recurrent urinary tract infections, and post-operative dental and surgical infections.
Amoxycillin 250mg + Potassium Clavulanate 50mg Injection
Amoxycillin and Potassium Clavulanate is a synergistic broad-spectrum antibacterial combination. Amoxycillin, an extended-spectrum aminopenicillin, inhibits bacterial cell wall peptidoglycan synthesis, while clavulanic acid, a beta-lactamase inhibitor, competitively binds and inactivates beta-lactamase enzymes produced by resistant bacteria, thereby safeguarding amoxycillin from enzymatic degradation. Indicated for acute otitis media, bacterial sinusitis, community-acquired pneumonia, skin and skin structure infections, recurrent urinary tract infections, and post-operative dental and surgical infections.
Amoxycillin 500mg + Potassium Clavulanate 100mg Injection
Amoxycillin and Potassium Clavulanate is a synergistic broad-spectrum antibacterial combination. Amoxycillin, an extended-spectrum aminopenicillin, inhibits bacterial cell wall peptidoglycan synthesis, while clavulanic acid, a beta-lactamase inhibitor, competitively binds and inactivates beta-lactamase enzymes produced by resistant bacteria, thereby safeguarding amoxycillin from enzymatic degradation. Indicated for acute otitis media, bacterial sinusitis, community-acquired pneumonia, skin and skin structure infections, recurrent urinary tract infections, and post-operative dental and surgical infections.